| Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse? M Kaza, M Karaźniewicz-Łada, K Kosicka, A Siemiątkowska, PJ Rudzki Journal of pharmaceutical and biomedical analysis 165, 381-385, 2019 | 123 | 2019 |
| Application of a microbiotests battery for complete toxicity assessment of rivers J Mankiewicz-Boczek, G Nałęcz-Jawecki, A Drobniewska, M Kaza, ... Ecotoxicology and Environmental Safety 71 (3), 830-836, 2008 | 117 | 2008 |
| Toxicity Assessment of Water Samples from Rivers in Central Poland Using a Battery of Microbiotests--a Pilot Study. M Kaza, J Mankiewicz-Boczek, K Izydorczyk, J Sawicki Polish Journal of Environmental Studies 16 (1), 2007 | 57 | 2007 |
| Rapid and simplified HPLC-UV method with on-line wavelengths switching for determination of capecitabine in human plasma E Piórkowska, M Kaza, J Fitatiuk, I Szlaska, T Pawiński, PJ Rudzki Die Pharmazie-An International Journal of Pharmaceutical Sciences 69 (7 …, 2014 | 32 | 2014 |
| Validated HPLC method for determination of temozolomide in human plasma. E Gilant, M Kaza, A Szlagowska, K Serafin-Byczak, PJ Rudzki Acta Poloniae Pharmaceutica 69 (6), 1347-1355, 2012 | 31 | 2012 |
| Validated HPLC method for determination of cefuroxime in human plasma. A Szlagowska, M Kaza, PJ Rudzki Acta Poloniae Pharmaceutica 67 (6), 677-681, 2010 | 24 | 2010 |
| The toxicity of selected pharmaceuticals to the aquatic plant Lemna minor M Kaza, G Nalecz-Jawecki, J Sawicki Fresenius Environmental Bulletin 16 (5), 524-531, 2007 | 23 | 2007 |
| Comprehensive graphical presentation of data from incurred sample reanalysis PJ Rudzki, P Biecek, M Kaza Bioanalysis 9 (12), 947-956, 2017 | 14 | 2017 |
| Kompleksowa analiza ekotoksykologiczna wód powierzchniowych J Sawicki, G Nałęcz-Jawecki, J Mankiewicz-Boczek, K Izydorczyk, ... Projekt MNiL, P05F, 2007 | 13 | 2007 |
| Incurred sample reanalysis: time to change the sample size calculation? PJ Rudzki, P Biecek, M Kaza The AAPS Journal 21 (2), 28, 2019 | 12 | 2019 |
| Validated HPLC-UV method for determination of naproxen in human plasma with proven selectivity against ibuprofen and paracetamol M Filist, I Szlaska, M Kaza, T Pawinski Biomedical Chromatography 30 (6), 953-961, 2015 | 9 | 2015 |
| Determination of duloxetine in human plasma with proven lack of influence of the major metabolite 4-hydroxyduloxetine M Kaza, E Gilant, M Filist, I Szlaska, T Pawiński, PJ Rudzki Clinical Biochemistry 47 (13-14), 1313-1315, 2014 | 9 | 2014 |
| Bioequivalence study of 500 mg cefuroxime axetil film-coated tablets in healthy volunteers. M Kaza, A Leś, K Serafin-Byczak, H Ksycińska, PJ Rudzki, P Gutkowskpi, ... Acta Poloniae Pharmaceutica 69 (6), 1356-1363, 2012 | 8 | 2012 |
| Evaluation of the toxicity of psychoactive compounds with the battery of bioassays G Nałęcz-Jawecki, M Kaza, J Sawicki Fresenius Environ Bull 17, 1257-1263, 2008 | 8 | 2008 |
| Incurred sample reanalysis: adjusted procedure for sample size calculation PJ Rudzki, K Buś-Kwaśnik, M Kaza Bioanalysis 9 (21), 1719-1726, 2017 | 6 | 2017 |
| HPLC-UV assay of imatinib in human plasma optimized for bioequivalence studies M Kaza, M Piórkowska, Edyta, Filist, P Rudzki Acta poloniae pharmaceutica 73 (6), 1495-1503, 2016 | 6 | 2016 |
| 10th Anniversary of a Two-Stage Design in Bioequivalence. Why Has it Still Not Been Implemented? M Kaza, A Sokolovskyi, PJ Rudzki Pharmaceutical Research 37, 1-5, 2020 | 4 | 2020 |
| Extended 3D and 4D cumulative plots for evaluation of unmatched incurred sample reanalysis PJ Rudzki, M Kaza, P Biecek Bioanalysis 10 (3), 153-162, 2018 | 4 | 2018 |
| Walidacja metod bioanalitycznych stosowanych w badaniach farmakokinetycznych M Kaza, A Szlagowska, P Rudzki Analiza Farmaceutyczna 65 (12), 839-844, 2009 | 3 | 2009 |
| Bioequivalence study of 8 mg ondansetron film-coated tablets in healthy Caucasian volunteers PJ Rudzki, M Kaza, A Leś, E Gilant, H Ksycińska, K Serafin-Byczak, ... Drug research, 220-224, 2013 | 2 | 2013 |
Piotr J. RudzkiCelon Pharma S.A.Zweryfikowany adres z celonpharma.com
